Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
170.30 EUR | +0.21% | -3.07% | +18.29% |
Sep. 03 | Merck Gets EU Approval for Keytruda Cancer Therapy | DJ |
Aug. 29 | Merck KGaA Doses First Patient in Late-stage Myasthenia Gravis Study | MT |
Capitalization | 73.89B 82.15B | P/E ratio 2024 * |
24.7x | P/E ratio 2025 * | 20.7x |
---|---|---|---|---|---|
Enterprise value | 80.8B 89.83B | EV / Sales 2024 * |
3.77x | EV / Sales 2025 * | 3.49x |
Free-Float |
29.72% | Yield 2024 * |
1.36% | Yield 2025 * | 1.51% |
Last Transcript: Merck KGaA
1 day | +0.28% | ||
1 week | -3.07% | ||
Current month | -3.07% | ||
1 month | +4.89% | ||
3 months | -0.84% | ||
6 months | +7.68% | ||
Current year | +18.29% |
Director | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 20-07-12 | |
Director of Finance/CFO | 54 | 19-04-25 | |
Danny Bar-Zohar
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-31 |
Manager | Title | Age | Since |
---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | - |
Jürgen Glaser
BRD | Director/Board Member | 61 | 12-04-30 |
Director/Board Member | 75 | 14-05-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.34% | 2 M€ | +13.56% | - | |
2.01% | 0 M€ | 0.00% | - | |
2.01% | 0 M€ | 0.00% | - | |
1.80% | 962 M€ | -.--% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.21% | -3.07% | +1.67% | -17.26% | 81.92B | ||
-0.06% | -3.70% | +21.36% | -19.24% | 11.74B | ||
-6.45% | -4.74% | +95.90% | +134.03% | 7.37B | ||
-3.26% | -9.57% | +27.92% | -16.80% | 6.1B | ||
+5.42% | +6.59% | -23.39% | -55.02% | 2.2B | ||
+0.19% | -5.27% | +8.22% | +11.93% | 2.04B | ||
+1.14% | -6.96% | -11.70% | +46.00% | 2B | ||
-1.77% | -1.77% | +8.25% | +25.20% | 1.89B | ||
-.--% | -.--% | - | - | 1.64B | ||
-7.97% | -11.69% | -54.00% | -17.38% | 1.57B | ||
Average | -1.28% | -3.17% | +8.25% | +10.16% | 11.85B | |
Weighted average by Cap. | -0.40% | -3.35% | +9.73% | -6.33% |
2024 * | 2025 * | |
---|---|---|
Net sales | 21.41B 23.8B | 22.58B 25.1B |
Net income | 2.99B 3.33B | 3.56B 3.95B |
Net Debt | 6.91B 7.69B | 5B 5.56B |
Date | Price | Change | Volume |
---|---|---|---|
24-09-06 | 170.45 € | +0.29% | 8,763 |
24-09-05 | 169.95 € | -1.28% | 330,089 |
24-09-04 | 172.15 € | -1.03% | 282,712 |
24-09-03 | 173.95 € | -0.71% | 148,354 |
24-09-02 | 175.20 € | -0.37% | 108,085 |
Delayed Quote Xetra, September 06, 2024 at 03:15 am EDT
More quotes- Stock Market
- Equities
- MRK Stock